LRB-2019/1
CMH:klm
2023 - 2024 LEGISLATURE
2023 ASSEMBLY JOINT RESOLUTIO N 13
March 6, 2023 - Introduced by Representatives SINICKI, CABRERA, BALDEH, CONLEY,
DRAKE, EDMING, EMERSON, JACOBSON, JOERS, MOORE OMOKUNDE, MURPHY,
ORTIZ-VELEZ, OHNSTAD, PALMERI, SHANKLAND, SHELTON and SUBECK,
cosponsored by Senators COWLES, HESSELBEIN, JACQUE, LARSON and SPREITZER.
Referred to Committee on Rules.
***AUTHORS SUBJECT TO CHANGE***
Relating to: designating June 2023 as Myasthenia Gravis Awareness Month.
Whereas, myasthenia gravis (MG) is an autoimmune neuromuscular disease
that causes chronic weakness, in which antibodies attack receptors in the body and
prevent muscle contraction; and
Whereas, MG frequently weakens muscles that control eye movement, facial
expressions, and swallowing, and its symptoms may include blurred vision, speech
impairment, difficulty chewing, shortness of breath, an unstable gait, and a
weakened grip; and
Whereas, a diagnosis of MG may be missed or delayed because it shares
symptoms in common with many other disorders; and
Whereas, in some cases, MG symptoms can worsen to the point of disability,
grave illness, or death, if there are gaps in or an absence of the several crucial health
care treatments that can enable those who endure MG to lead productive, active lives
of normal longevity; and
1
2
3
4
5
6
7
8
9
10
11
12
13
14 - 2 -
LRB-2019/1
CMH:klm
2023 - 2024 Legislature
Whereas, MG is found most commonly in adult women under 40 and men over
60, but is not specific to either gender or any particular ethnic background; and
Whereas, MG is nonhereditary and noncontagious; and
Whereas, 10 to 20 out of every 100,000 Americans are diagnosed with MG, and
support groups exist in Wisconsin for those people; now, therefore, be it
Resolved by the assembly, the senate concurring, That June 2023 is
hereby designated Myasthenia Gravis Awareness Month in Wisconsin.
(END)
1
2
3
4
5
6
7
8